Position in AZN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$148,727,743
New position
Shares Held
754,121
first reported quarter
Ownership
0.049%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 42.37821251496776.ToString("F0")%
Shared 0.20010051437368806.ToString("F0")%
None 57.421686970658556.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026TRUIST FINANCIAL CORP holds $2,326,875,887 across 16 Drug Manufacturers - General names. AZN ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,404,493 | $522,953,181 | |
| 2 | JNJ |
Johnson & Johnson
|
2,044,092 | $499,657,847 | |
| 3 | LLY |
ELI LILLY & Co
|
369,521 | $339,874,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,221,085 | $267,174,314 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
754,121 | $148,727,743 | |
| 6 | NVS |
Novartis AG
|
941,818 | $143,862,698 | |
| 7 | AMGN |
Amgen Inc
|
407,214 | $143,278,245 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,272,131 | $77,154,744 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $148,727,743 | 754,121 | Shares | Defined | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||